Investigating synaptic impairments in mouse models of Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy
Year: 2025
Type: dissertation
Abstract: Amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA) are two devastating neurodegenerative diseases leading to the loss of muscle strength in severe cases and respiratory failure is the most common cause of death in patients affected with these pathologies. ALS and SMA emanate from gene mutations and are generally characterized by muscle wasting arising from a selective dysfunction and death of neurons (MNs) of the spinal cord. Past studies have reported the involvement of synaptic impairments in early pathological events, leading to motor function decline and disease phenotype in both diseases. Although significant advances have been made in identifying specific biomarkers implicated in the pathomechanisms of ALS and SMA, the crosstalk between MN death and synaptic impairment is still not fully established in these neurological disorders. In the course of this work, various synaptic inputs onto spinal MNs were investigated, primarily focusing on proprioceptive synapses (PS) to determine the correlation between MN death and synaptic degeneration at different disease stages. Using immunohistochemistry and confocal microscopy a time course analysis was conducted in murine models of ALS and SMA, to study the loss of synaptic inputs on MNs in proximal and distal motor circuits. The SOD1-G93A mouse model of ALS revealed a segment-specific central synaptic degeneration at different stages of the disease. While MN loss was predominantly observed at the disease end stage in proximal motor circuits, PS degeneration was a much earlier event in these regions. Accordingly, the more vulnerable distal motor circuits revealed pre-symptomatic and progressive PS impairments on MN soma and dendrites. Correspondingly, cholinergic boutons (c-boutons) on MN soma showed aberrations as the disease progressed in SOD1-G93A mice. While a normal c-bouton development was noticed in SOD1WT mice, SOD1-G93A mice exhibited pre-symptomatic impairments on MNs innervating proximal and distal muscles, with no further development until the disease end stage. Compared to SOD1WT mice, a reduced VGluT2 synaptic coverage was observed at the final disease stages in SOD1-G93A mice, further contributing to the degeneration of central excitatory inputs on MNs in proximal and distal motor circuits. Moreover, VGAT synaptic coverage was significantly decreased on MN soma in SOD1-G93A mice at the disease end stage, highlighting the involvement of inhibitory synaptic loss in the ALS phenotype in mice. Altogether, the SOD1-G93A mouse model of ALS demonstrated significant synaptic impairments in vulnerable and more resistant motor circuits as the disease progresses. Furthermore, PS loss in proximal and distal motor circuits of three SMA mouse models was shown in this study. It was demonstrated that significant loss of PS occurs before MN death in severe and mild SMA mice. Additionally, it was observed that a severe SMA mouse model exhibits axonal sprouting and NMJ re-innervation through chronic enhancement of neuronal activity via the administration of an FDA-approved potassium channel blocker. Conclusively, this work represents the first segment-specific characterization of synaptic impairments in the SOD1-G93A mouse model of ALS at different disease stages. PS loss was depicted in vulnerable and resistant motor circuits of three SMA mouse models. These two neurodegenerative disorders exhibit PS degeneration in proximal and distal motor circuits and different disease stages. Functional analysis of these synapses in both proximal and distal motor circuits at different disease stages would advance our knowledge of their involvement in the mechanisms underlying motor circuit dysfunction in ALS and SMA. A segment-specific investigation of inhibitory synapses, together with the corresponding functional analysis in healthy and pathological conditions would shed light on the extent of excitatory and inhibitory synaptic dysfunction and loss in ALS mice. This would provide insights into how much neuronal activity is required to attain the excitatory/inhibitory balance necessary to restore motor output and improve disease phenotype in ALS mice.
Author: Siemund, Josiane Kelly
Institution: Leipzig University
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7154808170
